1. The 2012 Canadian Cardiovascular Society Heart Failure Management Guidelines Update: Focus on Acute and Chronic Heart Failure 
Robert S. McKelvie, MD, PhD, FRCPC, Gordon W. Moe, MD, FRCPC, Justin A. Ezekowitz, MB, BCh, MSc, FRCPC, George A. Heckman, MD, MSc, FRCPC, Jeannine Costigan, RN, MScN, APN, Anique Ducharme, MD, FRCPC, Estrellita Estrella-Holder, RN, BN, MScA, CCN(C), Nadia Giannetti, MD, FRCPC, Adam Grzeslo, MD, CCFP, FCFP, Karen Harkness, RN, BScN, CCNC, PhD, Jonathan G. Howlett, MD, FRCPC, Simon Kouz, MD, FRCPC, FACC, Kori Leblanc, BScPhm, ACPR PharmD, Elizabeth Mann, MD, FRCPC, FACP, Anil Nigam, MD, MSc, FRCPC, Eileen O'Meara, MD, FRCPC, Miroslaw Rajda, MD, FRCPC, Brian Steinhart, MD, FRCPC, Elizabeth Swiggum, MD, FRCPC, Vy Van Le, MD, FRCPC, Shelley Zieroth, MD, FRCPC, J. Malcolm O. Arnold, MD, FRCPC, Tom Ashton, MD, FRCPC, Michel D'Astous, MD, FRCPC, Paul Dorian, MD, FRCPC, Haissam Haddad, MD, FRCPC, Debra L. Isaac, MD, FRCPC, Marie- Hélène Leblanc, MD, FRCPC, Peter Liu, MD, FRCPC, Vivek Rao, MD, PhD, FRCPS, Heather J. Ross, MD, FRCPC, Bruce Sussex, MD, FRCPC 
Canadian Journal of Cardiology 
Volume 29, Issue 2, Pages (February 2013)
DOI: /j.cjca
Copyright © 2013 Canadian Cardiovascular Society Terms and Conditions

2. Figure 1
Algorithm for diagnosis of heart failure. CBC, complete blood count; CT, computed tomography. *Normal ejection fraction does not rule out heart failure with preserved ejection fraction.
Adapted with permission from Arnold et al.4
Canadian Journal of Cardiology  , DOI: ( /j.cjca )
Copyright © 2013 Canadian Cardiovascular Society Terms and Conditions

3. Figure 2
Pharmacologic management options for symptomatic heart failure with reduced ejection fraction (≤ 40%). ARB, angiotensin receptor blocker; ACE, angiotensin-converting enzyme; MRA, mineralocorticoid receptor antagonist; NYHA, New York Heart Association.
Canadian Journal of Cardiology  , DOI: ( /j.cjca )
Copyright © 2013 Canadian Cardiovascular Society Terms and Conditions